All publications
Predicting NNRTI resistance - do polymorphisms matter? 18th Conference on Retroviruses and Opportunistic Infections, 27 Feb - 2 Mar 2011.
.
2011. Prevalence and predictors of protease inhibitor (PI) mutations in HIV-infected UK adults treated with ritonavir-boosted lopinavir as their first PI. 17th Annual Conference of the British HIV Association, 6-8 April 2011.
.
2011. Transmission network parameters estimated from HIV sequences for a nationwide epidemic. J Infect Dis. 204:1463-9.
.
2011. Analysis of the Degree Distribution of HIV Transmission Networks Inferred from Viral Sequence Data. 17th Conference on Retroviruses and Opportunistic Infections, February 2010.
.
2010. Antiretroviral drug resistance in HIV-1-infected patients with low-level viremia. J Infect Dis. 201:1303-7.
.
2010. Bayesian Phylogeography of HIV among MSM in the UK Indicates a Few Source Areas of Widespread Infection. 17th Conference on Retroviruses and Opportunistic Infections, February 2010.
.
2010. The effect of transmitted HIV-1 drug resistance on pre-therapy viral load. AIDS. 24:1917-22.
.
2010. The effect of transmitted HIV-1 drug resistance on pre-therapy viral load. International HIV & Hepatitis Virus Drug Resistance Workshop & Curative Strategies, June 2010.
.
2010. Epidemiology of non-B clade forms of HIV-1 in men who have sex with men in the UK. AIDS. 24:2397-401.
.
2010. HIV type-1 drug resistance in antiretroviral treatment-naive adults infected with non-B subtype virus in the United Kingdom. Antivir Ther. 15:985-91.
.
2010. The HIV-1 subtype C epidemic in South America is linked to the United Kingdom. PLoS One. 5:e9311.
.
2010. The impact of the 0-0 cell on measures of amino acid covariation. AIDS. 24:159-60.
.
2010. Impact of transmitted drug-resistance on treatment selection and outcome of first-line Highly Active Antiretroviral Therapy (HAART). J Acquir Immune Defic Syndr. 53:633-9.
.
2010. Long-term probability of detecting drug-resistant HIV in treatment-naive patients initiating combination antiretroviral therapy. Clin Infect Dis. 50:1275-85.
.
2010. Positive and negative drug selection pressures on the N348I connection domain mutation: new insights from in vivo data. Antivir Ther. 15:203-11.
.
2010. The Prevalence of Darunavir Associated Mutations in PI-naive and PI-experienced HIV-1 Infected Children in the UK. 17th Conference on Retroviruses and Opportunistic Infections, February 2010.
.
2010. The biology, epidemiology and clinical implications of transmitted HIV drug resistant viruses. 16th Conference on Retroviruses and Opportunistic Infections, February 2009.
.
2009. Clustering and Geography: analysis of HIV transmission among UK MSM. 16th International HIV Dynamics & Evolution Meeting, April 2009.
.
2009. Demonstration of sustained drug-resistant HIV-1 lineages circulating among treatment-naïve individuals. 16th Conference on Retroviruses and Opportunistic Infections, February 2009.
.
2009. .
2009.